PPAR expression and its association with SOD and NF-κB in rats with obstructive jaundice

Biomedical Research (India)

Volumn 23, Issue 4, 2012, Pages 551-560

  Gong, Peng ^a   Xu, Haibo ^b   Zhang, Jianing ^a   Wang, Zhongyu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Liver; Nf B; Nuclear factor B; Obstructive jaundice; Peroxisome proliferators activated receptors; PPARs; SOD; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BLOOD SAMPLING; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR PATHOLOGY; NONHUMAN; OBSTRUCTIVE JAUNDICE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

EID: 84867262048     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645-650.
2. Staels B, Fruchart JC. Therapeutic Roles of Peroxisome Proliferator-Activated Receptor Agonists. Diabetes 2005; 54: 2460-2470.
3. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002; 53: 409-435
4. Ricote M, Li AC, Willson TM., et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82.
5. Moraes LA, Piqueras L, Ishop-Bailey D. Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther 2006; 110: 371-385.
6. David Bishop-Bailey, Jonas Bystrom. Emergingroles of peroxisome proliferator-activated receptor-β/δ in inflammation. Pharmacology & Therapeutics 2009; 2: 141-150.
7. Rodríguez-Calvo R, Serrano L, Coll T, et al. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2. Diabetes 2008; 57: 2149-2157.
8. Gong P, Wang Z, Zhao Z, et al. Expression of TNF-α and Superoxide Dismutase mRNA in Myocardium of Rats with Obstructive Jaundice. Chinese Journal of Bases and Clinics in General Surgery 2004; 11: 502-504.
9. Gong P, Wang Z, Wang H, et al. Protective effects on toxicity of bile by SOD gene transfection hepatocytes of rat. Chinese Journal of Practical Surgery 2003; 22: 346-347.
10. Gong P, Wang Z, Wang H, Chen H, Guan F. Effect and Significance of Astragalus Membranaceus(AM) on Expression of TNFα and SOD Gene mRNA in Injury of Rat Myocardium with Obstructive Jaundice. Chinese Journal of Surgery of Integrated Traditional and Western Medicine 2003; 9: 165-170.
11. Gong P, Wang ZY, Wang HJ. Protective effects of pLNCX-SOD gene transfection on hepatocyte injury induced by obstructive jaundice in rats. Hepatobiliary Pancreat Dis Int 2007; 6: 194-198.
12. Musa Dirlik, Aydin Karahan, Hakan Canbaz. Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopolysaccharide-induced sepsis. Current Therapeutic Research 2009; 70: 299-315.
13. Wang P, Guan YF, Du H, et al. Induction of autophagy contributes to the neuroprotection of NAMPT in cerebral ischemic stroke. Autophagy 2011;Epub.
14. Wang P, Xu TY, Guan YF, et al. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate- activated kinase pathway. Ann Neurol 2011; 2: 360-374.
15. Wang P, Yang FJ, Du H, et al. Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction. Mol Med 2011; 5-6: 523-532.
16. Göttle P, Kremer D, Jander S, et al. Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann Neurol 2010; 68: 915-924.
17. Caglikulekci M, Dirlik M, Pata C, et al. Effect of Nacetylcysteine on blood and tissue lipid peroxidation in lipopolysaccharide-induced obstructive jaundice. J Invest Surg 2006; 19:175-184.
18. Toyama T, Nakamura H, Harano Y, et al. PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 2004; 324: 697-704.
19. Inoue I, Goto S, Matsunaga T, Nakajima T, et al. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 2001; 50: 3-11.
20. Schoemaker MH, Gommans WM, Conde de la Rosa L, et al. Resistance of rat hepatocytes against bile acidinduced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 2003; 39: 153-161.
21. Wullaert A, Heyninck K, Beyaert R. Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. Biochem Pharmacol 2006; 72: 1090-1101.
22. Bonofiglio D, Aquila S, Catalano S, et al. Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells. Mol Endocrinol 2006; 20: 3083-3092.
23. Lee SS, Pineau T, Drago J, et al. Targeted disruption of the alpha isoform of the peroxisome proliferatoractivated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995; 15: 3012-3022.
24. Staels B, Fruchart JC. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005; 54: 2460-2470.